Delivery Order SPE2DB24D1205-SPE2DB24FCTZK

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB20D2104|SPE2DB22FR87K, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,841.76 firm fixed-price delivery order is for the supply of 4556335438 - NEULASTA 6 MG/0.6 ML SYRINGE 0.6ML, with a completion date of February 22, 2022. The contract was awarded through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Neupogen 480 mcg/0.8 mL syringes. The contract is a firm-fixed-price delivery order with a ceiling value of $4,019.12 and a performance period through June 23, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, that serves as a comprehensive global...
This federal contract award is for the delivery of NEUPOGEN 480 MCG/1.6 ML VIAL 1.6ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $19,111.26, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the supply of 4567410518 LUPRON DEPOT 11.25 MG 3MO KITS, a specialty pharmaceutical product, with a ceiling value of $8,631.36 and a completion date of February 28, 2025. This contract does not...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of a medical product described as a "KIT LUPRON DEP-AD 1S", with a ceiling value of $28,439.15 and a period of performance through October 15, 2024. The contract is a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract runs through November 2026 and covers a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to...
This is a $16,462.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML medical products, with a period of performance through March 26, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a $24,928.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of 4,564,639,914 units of leuprolide 2-week 14 mg/2.8 ml kits to support military healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,816.10 firm fixed-price delivery order is for the procurement of pharmaceutical products, specifically "KIT LUPRON DEP-AD 1S", which are likely used to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits,...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCTZK
    Delivery Order

The federal government, through the Defense Logistics Agency (DLA), has awarded a $13,358.22 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,545,326 units of the Neulasta OnPro 6 mg/0.6 ml kit. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation, and the ultimate completion date is August 23, 2024.

Generated 11/21/24, 9:19 AM